Fetal hydrocephalus

Abstract

The aim of this study was to draw the attention of specialists faced with fetal hydrocephalus in the postnatal period to the possibilities of prenatal diagnosis and further monitoring by studying isolated and syndrome cases in fetuses. One hundred and nine fetuses from a total of 2238 autopsies were the subject of observation in this study. In 64 (58.7%) of the studied fetuses, isolated hydrocephalus was found, while the other 45 cases were associated with the following malformations: Arnold-Chiari type II, Dandy-Walker, stenosis of the aqueductus sylvii, agenesis of corpus callosum (partial and total) and numerical chromosomal aberrations such as trisomy 13, 15 and 18. In cases of isolated hydrocephalus and a stable condition of the fetus, it is possible to wait until the term, or to induce labor without danger to the child, followed by a shunting intervention.

Correlations between Ultrasound and Pathology in Fetal Ventricular System Anomalies

“…The role of consanguinity is also known for the occurrence of congenital malformations such as hydrocephalus, postaxial polydactyly of the hands, and defects of the lips and palate [13,14]. Almost all studies have documented a slightly higher percentage of male fetuses in cases of CH in live births and stillbirths as well as in fetopathologic autopsies [15][16][17][18]. Van Landingham et al did not find a difference in the genders of the children with hydrocephalus compared to the general population [4].…”

Curosurf surfactant application on preterm babies with respiratory complications-health-economic benefits

“…The surfactant therapy was promoted in the 80s and became the standard treatment for children with RDS or at RDS risk. It has been confirmed that surfactant therapy reduced extra-alveolar gas collection, neonatal mortality rate and mortality rate in suckling age as well as costs for treatment of the surviving infants 17 , 18 . Natural surfactants extracted from animal sources containing surfactant proteins (SP-B) and (SP-C), as well as synthetic surfactants with functional protein analogues of SP-A and SP-C have been comprehensively studied in preterm newborns with or at risk of RDS.…”